Lamotrigina
Lamictal e altri
Bibliografia - Quali fonti bibliografiche per Lamotrigina?
1. AIFA, Dear Letter, 19 giugno 2006.
2. Anderson G.D., Epilepsia, 2002, 43 suppl 3, 53.
3. Besag F.M. et al., Epilepsia, 1994, 35 Suppl. 7, 73.
4. Besag F.M. et al., Epilepsia, 1998, 39(2), 183.
5. Betts T. et al., Epilepsia, 1991, 32 suppl 2, S17.
6. Binnie C.D., Royal Society of Medicine Services International Congress and Symposium Series N. 204 ed. London: Royal Society of medicine Services Limited, 1993, 25.
7. Biton V. et al., Neurology, 2005, 65, 1737.
8. Blankenhorn V. et al., Epilepsia, 1992, 91, 473.
9. Blondin et al., Prim Care Companion J Clin Psychiatry, 2008, 10(3), 249.
10. Bowden C.L. et al., Arch. Gen. Psych., 2003, 60, 392.
11. Bowden C.L. et al., Am. J. Psychiatry, 2006, 163, 1199.
12. Brodie M.J. et al., Lancet, 1992, 339, 1397.
13. Brodie M.J. et al., Lancet, 1995, 345, 467.
14. Calabrese J.R. et al., J. Clin. Psychiatry, 1999, 60, 79.
15. Calabrese J.R. et al., J. Clin. Psychiatry, 2003, 64, 1013.
16. Clifford J.S. et al., Epilepsia, 1994, 35 Suppl. 8, 31.
17. Cohen A.S., Cephalalgia., 2007, 27(7), 824.
18. Contin M. et al., Epilepsia, 2006, 47(9), 1573.
19. Coulter D.A., J. Child Neurol., 1997, 12, S2.
20. Crawford P.M., Drug Saf., 2009, 32(4), 293.
21. Depot M. et al., Clin. Pharmacol. Ther., 1990, 48, 346.
22. Eberhard-Gran M. et al., CNS Drugs., 2006, 20(3), 187.
23. Ebert U. et al., Eur J Clin Pharmacol., 2000, 56(4), 299.
24. Epilepsy res., 2001, 47, 151.
25. Faught et al., Epilepsia, 1999, 40(8), 1135.
26. FDA, Communication Alert, 12 agosto 2010 http://www.fda.gov/
27. Fillastre J.P. et al., Drugs Exp Clin Res., 1993, 19(1), 25.
28. Fitton A., Goa K.L., Drugs, 1995, 50 (4), 691.
29. Foletti G. et al., J. Neurology, 1992, 239 Suppl. 2, S71.
30. Frye M.A. et al., J. Clin. Psychopharmacol., 2000, 20, 607.
31. Harchelroad et al., Vet. Hum. Toxicol., 1994, 36, 372.
32. Holmes L.B. et al., Birth defects Reasearch part A: Clinical and Molecular Teratology, 2006, 76 (5), 318.
33. Ichim L. et al., Ann. Clin. Psychiatry, 2000, 12, 5.
34. Johannessen Landmark C., Patsalos P.N., Expert Rev Neurother., 2010, 10(1), 119.
35. Kaufman K.R., Gerner R., Seizure, 1998, 7(2), 163.
36. Lampl C. et al., J Neurol Neurosurg Psychiatry., 2005, 76(12), 1730.
37. Lombroso C.T., Neurology, 1999, 52(6), 1191.
38. Madadi P, Ito S., Can Fam Physician., 2010, 56(11), 1132.
39. Makin A.J. et al., BMJ, 1995, 311, 292.
40. Malik K. et al., Pain Med., 2002, 3(2), 167.
41. Manent et al., Epilepsy Res., 2008, 78(2-3), 131.
42. Massenhaimer J.A. et al., Drug Safety, 2000, 22, 303.
43. McCleane G., Pain, 1999, 83, 105.
44. Mewasingh L. et al., Lancet, 2000, 356, 656.
45. Nelson K., Holmes L.B., NEJM, 1989, 320, 19.
46. Neurology, 2003, 61, 570.
47. Ogawa Y. et al., Epilepsy Res., 1991, 8(1), 75.
48. Padmanabhan et al., Birth Defects Res B Dev Reprod Toxicol., 2003, 68(5), 428.
49. Patorno E., Bohn R., JAMA, 2010, 303(14), 1401.
50. Posner J. et al., Br J Clin Pharmacol., 1989, 28(1), 117.
51. Posner J. et al., Pharm. Med., 1991, 1, 121.
52. Rowan A.J. et al., Neurology, 2005, 64 (11), 1868.
53. Rzany B. et al., Lancet., 1999, 353(9171), 2190.
54. Sabers A. et al., Neurology, 2003, 61(4), 570.
55. Sidhu J. et al., Br J Clin Pharmacol., 2006, 61(2), 191.
56. Simpson D.M. et al., Neurology, 2000, 54, 2115.
57. Steiner T.J. et al., Epilepsia, 1994, 35 Suppl. 7, 61.
58. Titlic M. et al., Bratisl Lek Listy., 2008, 109(9), 421.
59. Van Amelsvoort T. et al., Epilepsia, 1994, 35, 181.
60. Van der Lee M.J. et al., Clin Pharmacol Ther., 2006, 80(2), 159.
61. Yuen A.W.C. et al., Epilepsia, 1994, 35 Suppl. 8, 31.
62. Yuen A.W.C., Bihari D.J., Lancet, 1992, 340, 618.
63. Warner T. et al., Epilep. Res., 1992, 11, 147.
64. White H.S., Epilepsia, 1999, 40, S2.
65. Zakrzewska J.M. et al., Pain, 1997, 73, 223.
